Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
about
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosaGenotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic FibrosisHost derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis.Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.The population genetics of Pseudomonas aeruginosa isolates from different patient populations exhibits high-level host specificity.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsThe changing microbial epidemiology in cystic fibrosis.Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infectionsPseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung.Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosisClinical significance of microbial infection and adaptation in cystic fibrosis.Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum mediumLytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infectionsPhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patientsGenes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung Infections.Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patientsHealth-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosaPhenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain.Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.Identification of Novel Genomic Islands in Liverpool Epidemic Strain of Pseudomonas aeruginosa Using Segmentation and Clustering.Health-related quality of life measurement in cystic fibrosis: advances and limitations.Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types.
P2860
Q28492507-15A8751D-AF2F-45BA-9D54-1973DF93ACA1Q28551306-625D37C6-F6EE-4272-9B3A-461729B80BEEQ30425581-3108F27E-6DAE-4703-9D24-756949289EBCQ30862375-FBE11331-CE1B-449A-8F87-647DBF649B46Q33214091-237DC64B-48DA-448D-8878-E7D874615E4BQ33285539-DE8AE61E-F77C-435D-B940-154B3242F1D8Q33346997-002AE611-AF32-4768-9F5C-886ED9E484EDQ33728209-10EC749A-1C5A-4ECF-86DB-9A4F03D8C734Q33786154-902E30C7-FA1B-4EEF-9D1C-C5897806098FQ33825634-62502590-79BE-45EC-9190-1DA7CC8B484CQ33909400-72E2264B-A2B0-4E24-8F86-ABF9554D9A47Q34026130-C258CDF8-BA3C-485E-84C5-7FF8240BD2D8Q34418832-831A1092-048D-4E4C-9533-3500DDDD1579Q34487493-80F40D68-5A4C-41A2-BF17-2BB5C8B1C384Q34491552-26C8DEE6-B0E3-477A-A72B-99F116019A25Q34565049-620F5E7C-009A-4EC4-A407-A9A49646381DQ34860393-938CF793-F08C-492C-8647-08FF35609BA7Q35154348-3A5A9C3A-43C6-4EB5-B8C5-BCE3AC63856AQ35530910-CB6C02C5-C514-497B-A02A-FD250B64DAECQ35598578-58569837-658E-4C5D-AB5C-1DB86215D62AQ35744602-6D819C8F-E670-403D-B02F-3B84812D75DDQ35746038-D587810A-10CD-47C5-93CE-2049AF153878Q35761876-EE07CCBC-B592-4255-A98D-51CDF41350E8Q35784162-61BC5997-F8B7-476A-A5FD-FBBC95B24205Q35793872-3A1C3429-12BA-4427-A7B8-27F747BB83FDQ35834075-E8F69736-D894-4008-8C18-594628C2EB6DQ35849694-A08164A3-C5EA-41DA-BD2F-0E5B74B3BB86Q36046509-7C641BE7-F612-42AE-BB2F-8DF34FE94D8AQ36051231-E9705A7F-B783-45B0-BF00-79BAA233F5EBQ36060289-FDBECF7F-180D-4F87-A0CD-AD3E9513D65BQ36072879-0A58A5A0-2C86-47BE-8948-91BD3CE480F8Q36270239-FAEFEF34-D4E5-4979-BC1B-26D859D6CA10Q36670892-39983C84-85EF-4D56-ABD0-29C10536BE5EQ36739797-53E91A23-0E54-422D-AD1D-416AACFAC79DQ36884485-1F3C251B-7467-4235-B442-81D7D9E9D892Q36895659-C9A6E199-FA73-4EF4-95CA-15B11B47EB80Q37148226-327DFC7F-36B6-48EE-B829-1BF5A1C7B930Q37379589-ECB287C1-9672-4511-AF7A-2F7CBEC006EFQ37421177-78956E76-C68F-4914-BEF9-5746731E4891Q37451717-6B40B675-A7A0-45F6-9D0E-74C8B7EA9E21
P2860
Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Increased morbidity associated ...... uginosa strain in CF patients.
@ast
Increased morbidity associated ...... uginosa strain in CF patients.
@en
type
label
Increased morbidity associated ...... uginosa strain in CF patients.
@ast
Increased morbidity associated ...... uginosa strain in CF patients.
@en
prefLabel
Increased morbidity associated ...... uginosa strain in CF patients.
@ast
Increased morbidity associated ...... uginosa strain in CF patients.
@en
P2093
P2860
P356
P1433
P1476
Increased morbidity associated ...... uginosa strain in CF patients.
@en
P2093
P2860
P304
P356
10.1136/THX.2003.014258
P407
P577
2004-04-01T00:00:00Z